Allergy Therapeutics (AGY) — Free Cash Flow Generation Index
Allergy Therapeutics (AGY) has a Free Cash Flow Generation Index of 0.69x as of December 2021. Free cash flow of GBX2.56 Million represents 1% of operating cash flow (GBX3.71 Million). Read Allergy Therapeutics balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Allergy Therapeutics Free Cash Flow Generation Index (2003–2021)
Historical FCF Generation Index trend for Allergy Therapeutics across 11 annual periods. Explore AGY capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Allergy Therapeutics (2003–2021)
Year-by-year Free Cash Flow Generation Index for Allergy Therapeutics. For the full company profile including market capitalisation, see market value of Allergy Therapeutics.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.70x | GBX5.95 Million | GBX8.52 Million | GBX2.56 Million | ▼ -11.8% |
| 2020 | 0.79x | GBX9.73 Million | GBX12.28 Million | GBX2.55 Million | ▲ +59.1% |
| 2019 | 0.50x | GBX2.79 Million | GBX5.60 Million | GBX2.81 Million | ▲ +106.7% |
| 2017 | -7.43x | GBX-1.32 Million | GBX178.00K | GBX1.50 Million | ▼ -1241.5% |
| 2015 | 0.65x | GBX2.03 Million | GBX3.12 Million | GBX1.09 Million | ▲ +10.9% |
| 2014 | 0.59x | GBX1.27 Million | GBX2.17 Million | GBX898.00K | ▼ -11.4% |
| 2013 | 0.66x | GBX1.61 Million | GBX2.43 Million | GBX821.00K | ▲ +17.8% |
| 2012 | 0.56x | GBX1.62 Million | GBX2.88 Million | GBX1.26 Million | ▲ +23819.6% |
| 2010 | 0.00x | GBX4.00K | GBX1.70 Million | GBX1.70 Million | ▼ -99.6% |
| 2004 | 0.60x | GBX1.15 Million | GBX1.91 Million | GBX760.00K | ▼ -25.4% |
| 2003 | 0.81x | GBX1.69 Million | GBX2.10 Million | GBX406.00K | — |